2-year real-world outcomes of prasugrel, ticagrelor or clopidogrel therapy following percutaneous coronary intervention from a large multi-centre Australian registry.
Event:
ESC Congress 2020
Topic:
Pharmacotherapy
Session:
Acute Coronary Syndromes ePosters
